• Fri, May 5, 2023
Tiago Fauth Maintained (ABCL) at Buy with Decreased Target to $28 on, May 5th, 2023
Tiago Fauth of Credit Suisse, Maintained "AbCellera Biologics Inc." (ABCL) at Buy with Decreased Target from $34 to $28 on, May 5th, 2023.
Tiago has made no other calls on ABCL in the last 4 months.
There are 3 other peers that have a rating on ABCL. Out of the 3 peers that are also analyzing ABCL, 0 agree with Tiago's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Tiago
- Steven Mah of "Cowen & Co." Initiated at Buy on, Tuesday, February 28th, 2023
- Gary Nachman of "BMO Capital" Maintained at Buy with Decreased Target to $32 on, Wednesday, February 22nd, 2023
- Puneet Souda of "SVB Leerink" Maintained at Buy with Decreased Target to $18 on, Friday, January 6th, 2023
Like: 👍
